Cargando…

Application of Antibody-Mediated Therapy for Treatment and Prevention of Clostridium difficile Infection

Clostridium difficile causes antibiotic- and healthcare-associated diarrhea, which is characterized by a high mortality rate (5–15%) and high recurrence rate of 20% or more. Therapeutic alternatives to antibiotics are urgently needed to improve the overall cure rate. Among these, therapeutic antibod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Förster, Beatrix, Chung, Pui Khi, Crobach, Monique J. T., Kuijper, Ed J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027166/ https://www.ncbi.nlm.nih.gov/pubmed/29988597 http://dx.doi.org/10.3389/fmicb.2018.01382

Ejemplares similares

Clostridium difficile infection in an endemic setting in the Netherlands
por: Hensgens, M. P. M., et al.
Publicado: (2010)

Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections
por: Baktash, Amoe, et al.
Publicado: (2018)

Clostridium difficile Infection Caused by Binary Toxin–Positive Strains
por: Hensgens, Marjolein P.M., et al.
Publicado: (2013)

Clostridium difficile infection: review
por: Czepiel, Jacek, et al.
Publicado: (2019)

The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016
por: Novakova, Elena, et al.
Publicado: (2020)

Clostridium difficile phages: still difficult?
por: Hargreaves, Katherine R., et al.
Publicado: (2014)

Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection
por: Péchiné, Séverine, et al.
Publicado: (2018)

Host Immune Responses to Clostridioides difficile: Toxins and Beyond
por: Nibbering, Britt, et al.
Publicado: (2021)

Typing Clostridium difficile strains based on tandem repeat sequences
por: Zaiß, N Henning, et al.
Publicado: (2009)

Toxin release mediated by the novel autolysin Cwp19 in Clostridium difficile
por: El Meouche, Imane, et al.
Publicado: (2018)

Clostridium difficile – From Colonization to Infection
por: Schäffler, Holger, et al.
Publicado: (2018)

TcdC Does Not Significantly Repress Toxin Expression in Clostridium difficile 630ΔErm
por: Bakker, Dennis, et al.
Publicado: (2012)

Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens
por: Venhorst, Jennifer, et al.
Publicado: (2022)

Isolation of recombinant antibodies directed against surface proteins of Clostridium difficile
por: Shirvan, Ali Nazari, et al.
Publicado: (2016)

Clostridium difficile TcdC protein binds four-stranded G-quadruplex structures
por: van Leeuwen, Hans C., et al.
Publicado: (2013)

New Insights Into Functions and Possible Applications of Clostridium difficile CRISPR-Cas System
por: Maikova, Anna, et al.
Publicado: (2018)

The Bacterial Gut Microbiota of Adult Patients Infected, Colonized or Noncolonized by Clostridioides difficile
por: Crobach, Monique J. T., et al.
Publicado: (2020)

Clostridium difficile Ribotype 027, Toxinotype III, the Netherlands
por: Kuijper, Ed J., et al.
Publicado: (2006)

Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection
por: Navalkele, Bhagyashri D, et al.
Publicado: (2018)

High Prevalence of Clostridium difficile Colonization among Nursing Home Residents in Hesse, Germany
por: Arvand, Mardjan, et al.
Publicado: (2012)

Non-toxigenic Clostridioides (Formerly Clostridium) difficile for Prevention of C. difficile Infection: From Bench to Bedside Back to Bench and Back to Bedside
por: Gerding, Dale N., et al.
Publicado: (2018)

Editorial: Alternative Therapeutic Approaches For Multidrug Resistant Clostridium difficile
por: Janvilisri, Tavan, et al.
Publicado: (2019)

Seasonality of Clostridium difficile infections in Southern Germany
por: REIL, M., et al.
Publicado: (2012)

Structural Insights into Substrate Recognition by Clostridium difficile Sortase
por: Yin, Jui-Chieh, et al.
Publicado: (2016)

Characterization of Bacteriophages Infecting Clinical Isolates of Clostridium difficile
por: Phothichaisri, Wichuda, et al.
Publicado: (2018)

Bacteriophages Contribute to Shaping Clostridioides (Clostridium) difficile Species
por: Fortier, Louis-Charles
Publicado: (2018)

Antimicrobial susceptibility profiles of human and piglet Clostridium difficile PCR-ribotype 078
por: Keessen, Elisabeth C, et al.
Publicado: (2013)

Structural and functional changes in the gut microbiota associated to Clostridium difficile infection
por: Pérez-Cobas, Ana E., et al.
Publicado: (2014)

Data from a survey of Clostridium perfringens and Clostridium difficile shedding by dogs and cats in the Madrid region (Spain), including phenotypic and genetic characteristics of recovered isolates
por: Álvarez-Pérez, Sergio, et al.
Publicado: (2017)

The Monoclonal Antitoxin Antibodies (Actoxumab–Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with Clostridium difficile Infection
por: Džunková, Mária, et al.
Publicado: (2016)

Preliminary studies on isolates of Clostridium difficile from dogs and exotic pets
por: Andrés-Lasheras, Sara, et al.
Publicado: (2018)

Probing Clostridium difficile Infection in Complex Human Gut Cellular Models
por: Anonye, Blessing O., et al.
Publicado: (2019)

Chemical and Stress Resistances of Clostridium difficile Spores and Vegetative Cells
por: Edwards, Adrianne N., et al.
Publicado: (2016)

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile
por: Binyamin, Dana, et al.
Publicado: (2018)

Protective Effects of Bifidobacterial Strains Against Toxigenic Clostridium difficile
por: Wei, Yanxia, et al.
Publicado: (2018)

An Engineered Synthetic Biologic Protects Against Clostridium difficile Infection
por: Vedantam, Gayatri, et al.
Publicado: (2018)

Effect of Bifidobacterium breve in Combination With Different Antibiotics on Clostridium difficile
por: Yang, Jingpeng, et al.
Publicado: (2018)

A Review of Mixed Strain Clostridium difficile Colonization and Infection
por: Dayananda, Pete, et al.
Publicado: (2019)

Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection
por: Kers, Johan A., et al.
Publicado: (2018)

Emergence of Clostridium difficile Ribotype 027 in Korea
por: Kim, Heejung, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_t8t77g9furn2ucj35c3hu492ca